Effects of short-term estrogen treatment on the progression of N-methyl-Nnitrosourea-induced premalignant mammary lesions in female Lewis rats

Medical Molecular Morphology

Volumn 44, Issue 3, 2011, Pages 125-130

  Yuri, Takashi ^a   Lai, Yen Chang ^a   Kanematsu, Sayaka ^a   Kuwata, Maki ^a   Yoshizawa, Katsuhiko ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Cyclin D1; Ductal carcinoma in situ; Ductal hyperplasia; Estrogen; N Methyl Nnitrosourea; Rat

Indexed keywords

CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; N METHYL N NITROSOURETHAN; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST DISEASE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; HYPERPLASIA; INTRADUCTAL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; ESTROGENS; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED LEW;

EID: 81355141968     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-010-0515-2     Document Type: Review

References (33)

1. Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33:315-318
2. Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55-67 (Pubitemid 38781751)
3. Nandi S, Guzman RC, Thordarson G, Rajkumar L (2005) Estrogen can prevent breast cancer by mimicking the protective effect of pregnancy. In: Li JJ, Li SA, Llombart-Bosch A (eds) Hormonal carcinogenesis, vol IV. Springer, New York, pp 165-179
4. Tsubura A, Uehara N, Matsuoka Y, Yoshizawa K, Yuri T (2008) Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer. In Vivo 22:191-202 (Pubitemid 351523556)
5. Santen RJ (2007) The oestrogen paradox: a hypothesis. Pol J Endocrinol 58:222-227
6. Thompson HJ, McGinley JN, Rothhammer K, Singh M (1995) Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis (Oxf) 16:2407-2411
7. Thompson HJ, McGinley JN, Wolfe P, Singh M, Steele VE, Kelloff GJ (1998) Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis (Oxf) 19:2181-2185 (Pubitemid 29010260)
8. Singh M, McGinley JN, Thompson HJ (2000) A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest 80:221-231 (Pubitemid 30120974)
9. Tsubura A, Yoshizawa K, Uehara N, Yuri T, Matsuoka Y (2007) Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential. Med Mol Morphol 40:9-17 (Pubitemid 46475024)
10. Isaacs JT (1986) Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46:3958-3963 (Pubitemid 16075891)
11. Yang J, Yoshizawa K, Nandi S, Tsubura A (1999) Protective effects of pregnancy and lactation against N-methyl-N-nitrosoureainduced mammary carcinomas in female Lewis rats. Carcinogenesis (Oxf) 20:623-628 (Pubitemid 29151298)
12. Silvera SAN, Rohan TE (2008) Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat 110:397-409 (Pubitemid 351962587)
13. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (1999) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1990. Arch Pathol Lab Med 124:966-978
14. Moriya T, Kasajima A, Ishida K, Kariya Y, Akahira J, Endoh M, Watanabe M, Sasano H (2006) New trends of immunohistochemistry for making differential diagnosis of breast lesions. Med Mol Morphol 39:8-13 (Pubitemid 44306504)
15. Thompson HJ, Singh M, McGinley J (2000) Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1- nitrosourea. J Mammary Gland Biol Neoplasia 5:201-210 (Pubitemid 32045696)
16. Tan PH, Aw MY, Yip G, Bay BH, Sii LH, Murugaya S, Tse GM (2005) Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 29:625-632 (Pubitemid 40577872)
17. Huggins C, Moon RC, Morii S (1962) Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci U S A 48:379-386
18. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S (2001) Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A 98:11755-11759 (Pubitemid 32928801)
19. Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D (2007) Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9:R12
20. MacMahon B, Cole P, Brown J (1973) Etiology of human breast cancer: a review. J Natl Cancer Inst 50:21-42
21. Korkola JE, Wood GA, Archer MC (1999) Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat. Breast Cancer Res 1:88-94 (Pubitemid 32223551)
22. Thompson HJ, McGinley J, Rothhammer K, Singh M (1998) Ovarian hormone dependence of pre-malignant and malignant mammary gland lesions induced in pre-pubertal rats by 1-methyl- 1-nitrosourea. Carcinogenesis (Oxf) 19:383-386 (Pubitemid 28375438)
23. Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D (2009) Progesterone and normal human breast. Breast Cancer Res Treat 118:161-168
24. Krishnamurthy S, Sneige N (2002) Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol 9: 185-197
25. Sivaraman L, Hilsenbeck SG, Zhong L, Gay J, Conneely OM, Medina D, O'Malley BW (2001) Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation. J Endocrinol 171: 75-83 (Pubitemid 32975921)
26. Hunter T, Pines J (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582 (Pubitemid 24363801)
27. Zhu XL, Hartwick W, Rohan T, Kandel R (1998) Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Mod Pathol 11:1082-1088 (Pubitemid 28525015)
28. Dong Y, Asch HL, Medina D, Ip C, Ip M, Guzman R, Asch BB (1999) Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers. Int J Cancer 81: 930-938 (Pubitemid 29249979)
29. Alle KM, Henshall SM, Field AS, Sutherland RL (1998) Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4:847-854 (Pubitemid 28183384)
30. Zhu Z, Jiang W, Thompson HJ (1999) Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinog 24:241-245 (Pubitemid 29232644)
31. Sgambato A, Han EK, Zhang YJ, Moon RC, Santella RM, Weinstein IB (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis (Oxf) 16:2193-2198
32. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond) 369:669-671 (Pubitemid 24199473)
33. Sutherland RL, Musgrove EA (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9:95-104 (Pubitemid 39137499)